In addition, a number of studies have reported that COX-2 was highly expressed in prostate cancer and stimulated prostate cancer cell proliferation (Gupta et al., 2000; Dandekar and Lokeshwar, 2004; Richardsen et al., 2010). Here, PTGS2 is linked to prostate carcinoma.